Development of CAR T-cell lymphoma in 2 of 10 patients effectively treated with piggyBac-modified CD19 CAR T cells.

Bishop, DC; Clancy, LE; Simms, R; Burgess, J; Mathew, G; Moezzi, L; Street, JA; Sutrave, G; Atkins, E; McGuire, HM; Gloss, BS; Lee, K; Jiang, W; Maddock, K; McCaughan, G; Avdic, S; Antonenas, V; O'Brien, TA; Shaw, PJ; Irving, DO; Gottlieb, DJ; Blyth, E; Micklethwaite, KP

Development of CAR T-cell lymphoma in 2 of 10 patients effectively treated with piggyBac-modified CD19 CAR T cells.

Bishop, DC Clancy, LE Simms, R Burgess, J Mathew, G Moezzi, L Street, JA Sutrave, G Atkins, E McGuire, HM Gloss, BS Lee, K Jiang, W Maddock, K McCaughan, G Avdic, S Antonenas, V O'Brien, TA Shaw, PJ Irving, DO Gottlieb, DJ Blyth, E Micklethwaite, KP

Permalink

Publisher:: American Society of Hematology
Publication Type:: Journal Article
Citation:: Blood, 2021, 138, (16), pp. 1504-1509
Issue Date:: 2021-10-21

Closed Access

	Filename	Description	Size
	Development of CAR T-cell lymphoma.pdf	Published version	1.13 MB	Adobe PDF	View/Open

Copyright Clearance Process

Recently Added
In Progress
Closed Access

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Bishop, DC
dc.contributor.author	Clancy, LE
dc.contributor.author	Simms, R
dc.contributor.author	Burgess, J
dc.contributor.author	Mathew, G
dc.contributor.author	Moezzi, L
dc.contributor.author	Street, JA
dc.contributor.author	Sutrave, G
dc.contributor.author	Atkins, E
dc.contributor.author	McGuire, HM
dc.contributor.author	Gloss, BS
dc.contributor.author	Lee, K
dc.contributor.author	Jiang, W
dc.contributor.author	Maddock, K
dc.contributor.author	McCaughan, G
dc.contributor.author	Avdic, S
dc.contributor.author	Antonenas, V
dc.contributor.author	O'Brien, TA
dc.contributor.author	Shaw, PJ
dc.contributor.author	Irving, DO
dc.contributor.author	Gottlieb, DJ
dc.contributor.author	Blyth, E
dc.contributor.author	Micklethwaite, KP
dc.date.accessioned	2022-02-07T04:05:49Z
dc.date.available	2021-04-13
dc.date.available	2022-02-07T04:05:49Z
dc.date.issued	2021-10-21
dc.identifier.citation	Blood, 2021, 138, (16), pp. 1504-1509
dc.identifier.issn	0006-4971
dc.identifier.issn	1528-0020
dc.identifier.uri	http://hdl.handle.net/10453/154244
dc.language	eng
dc.publisher	American Society of Hematology
dc.relation.ispartof	Blood
dc.relation.isbasedon	10.1182/blood.2021010813
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject	1102 Cardiorespiratory Medicine and Haematology, 1103 Clinical Sciences, 1114 Paediatrics and Reproductive Medicine
dc.subject.classification	Immunology
dc.subject.mesh	Adult
dc.subject.mesh	Aged
dc.subject.mesh	DNA Transposable Elements
dc.subject.mesh	Female
dc.subject.mesh	Hematopoietic Stem Cell Transplantation
dc.subject.mesh	Humans
dc.subject.mesh	Immunotherapy, Adoptive
dc.subject.mesh	Leukemia, B-Cell
dc.subject.mesh	Lymphoma
dc.subject.mesh	Lymphoma, B-Cell
dc.subject.mesh	Male
dc.subject.mesh	Middle Aged
dc.subject.mesh	Receptors, Antigen, T-Cell
dc.subject.mesh	Treatment Outcome
dc.subject.mesh	Young Adult
dc.title	Development of CAR T-cell lymphoma in 2 of 10 patients effectively treated with piggyBac-modified CD19 CAR T cells.
dc.type	Journal Article
utslib.citation.volume	138
utslib.location.activity	United States
utslib.for	1102 Cardiorespiratory Medicine and Haematology
utslib.for	1103 Clinical Sciences
utslib.for	1114 Paediatrics and Reproductive Medicine
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/DVC (Research)
utslib.copyright.status	closed_access	*
dc.date.updated	2022-02-07T04:05:47Z
pubs.issue	16
pubs.publication-status	Published
pubs.volume	138
utslib.citation.issue	16

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/154244